U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
ABITUZUMAB
INN   WHO-DD  
INN  
Official Name English
abituzumab [INN]
Preferred Name English
EMD-525797
Code English
DI-17E6
Code English
EMD 525797
Code English
DI17E6
Code English
Abituzumab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G2-KAPPA, ANTI-(HOMO SAPIENS ITGAV (INTEGRIN ALPHAV, CD51)), HUMANIZED MONOCLONAL ANTIBODY
Common Name English
DI 17E6
Code English
Classification Tree Code System Code
NCI_THESAURUS C129822
Created by admin on Mon Mar 31 18:29:32 GMT 2025 , Edited by admin on Mon Mar 31 18:29:32 GMT 2025
NCI_THESAURUS C1742
Created by admin on Mon Mar 31 18:29:32 GMT 2025 , Edited by admin on Mon Mar 31 18:29:32 GMT 2025
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 18:29:32 GMT 2025 , Edited by admin on Mon Mar 31 18:29:32 GMT 2025
Code System Code Type Description
DRUG BANK
DB12775
Created by admin on Mon Mar 31 18:29:32 GMT 2025 , Edited by admin on Mon Mar 31 18:29:32 GMT 2025
PRIMARY
WIKIPEDIA
Abituzumab
Created by admin on Mon Mar 31 18:29:32 GMT 2025 , Edited by admin on Mon Mar 31 18:29:32 GMT 2025
PRIMARY
INN
9509
Created by admin on Mon Mar 31 18:29:32 GMT 2025 , Edited by admin on Mon Mar 31 18:29:32 GMT 2025
PRIMARY
EVMPD
SUB71901
Created by admin on Mon Mar 31 18:29:32 GMT 2025 , Edited by admin on Mon Mar 31 18:29:32 GMT 2025
PRIMARY
CAS
1105038-73-0
Created by admin on Mon Mar 31 18:29:32 GMT 2025 , Edited by admin on Mon Mar 31 18:29:32 GMT 2025
PRIMARY
NCI_THESAURUS
C82422
Created by admin on Mon Mar 31 18:29:32 GMT 2025 , Edited by admin on Mon Mar 31 18:29:32 GMT 2025
PRIMARY
SMS_ID
100000154445
Created by admin on Mon Mar 31 18:29:32 GMT 2025 , Edited by admin on Mon Mar 31 18:29:32 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109621
Created by admin on Mon Mar 31 18:29:32 GMT 2025 , Edited by admin on Mon Mar 31 18:29:32 GMT 2025
PRIMARY
EVMPD
SUB128906
Created by admin on Mon Mar 31 18:29:32 GMT 2025 , Edited by admin on Mon Mar 31 18:29:32 GMT 2025
PRIMARY
FDA UNII
724QD330RD
Created by admin on Mon Mar 31 18:29:32 GMT 2025 , Edited by admin on Mon Mar 31 18:29:32 GMT 2025
PRIMARY
ACTIVE MOIETY
ABITUZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966